Despite scientific progress over the past 25 years, dementia remains one of the toughest health-care challenges. Alzheimer’s disease is the sixth-leading cause of death in the United States, and the number of deaths from all related dementias may be twice as high. Years of investment and research in Alzheimer’s disease and related dementias (ADRD) are sowing seeds of hope. New treatments aim to slow cognitive decline and manage symptoms. However, because of the complexity of dementia, people living with dementia will likely need a combination of drug treatments, comprehensive care, and supportive services to help them live their lives to the fullest after diagnosis.
Advocacy organizations, policymakers, researchers, and health-care professionals are developing ways to meet the complex medical and social needs of the estimated 7.2 million Americans living with ADRD and their families. To advance the adoption of comprehensive dementia-care models, the Milken Institute Alliance to Improve Dementia Care convened a roundtable in June 2021. Leaders across industry, government, research, advocacy, philanthropy, health systems, and community-based organizations explored ways to improve and pay for comprehensive dementia care.
This report presents actionable recommendations to advance comprehensive dementia care and implement effective payment policies. These recommendations center around two overarching themes:
1. Developing a structured framework to test, implement, and scale comprehensive dementia-care models; and
2. Implementing effective payment policies to incentivize adoption and participation in comprehensive dementia-care models.
DOWNLOAD REPORT The prevalence of mild cognitive impairment (MCI) and dementia is increasing as advancements in medicine, public health, and living standards extend human lifespans. Approximately 12–18 percent of Americans aged 60 and older...
Sarah Lenz Lock, JD Senior Vice President, Policy & Brain Health and Executive Director, Global Council on Brain Health, AARP 1. You are a Steering Committee member of the Milken Institute Alliance to Improve Dementia Care. Describe the...
Q & A with David B. Reuben, MD Director, Multicampus Program in Geriatric Medicine and Gerontology, Chief, Division of Geriatrics, University of California, Los Angeles You are a member of the Milken Institute Alliance to Improve Dementia...
Q & A with Debra Cherry, PhD Executive Vice President, Alzheimer's Los Angeles You are a member of the Milken Institute Alliance to Improve Dementia Care. Describe the expertise that you bring to the Alliance and how the ideas explored...
The Alliance to Improve Dementia Care, part of the Milken Institute’s Center for the Future of Aging, utilizes a multi-sector approach to develop recommendations to improve care for individuals living with dementia across all stages...
Increased longevity is perhaps one of the greatest success stories of our modern public health system. But along with this success comes one of our greatest challenges to healthy longevity. As we age, the risk of neurodegenerative disease...
September 25, 2024 (Washington, DC)—The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), today announced...
Paul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence.
This report covers the challenges that the US health-care system is facing as it prepares to meet the growing demand for care among individuals living with Alzheimer’s disease and related dementias (ADRD). It suggests that implementing care...
Q & A with Matthew Baumgart Vice President of Health Policy, Alzheimer’s Association Shifting Focus: The Value of Investing in Dementia Treatment, Care, and Support 1. We are seeing record investment in developing therapeutics to slow...